But, I found a study that was helpful in breaking down this issue so that you can help your clients understand it as well
Consider: Baseline blood pressure and heart rate measurement before starting combination therapy Regular monitoring during dose titration of either medication Prompt evaluation of palpitations, chest pain, or shortness of breath Caution in patients with pre-existing cardiovascular disease , including coronary artery disease, arrhythmias, or uncontrolled hypertension ECG evaluation if indicated by clinical history or symptoms Nutritional adequacy must be maintained
Taspoglutide (a long acting GLP-1 agonist) was not found to have significant anti-atheromatous effects, although it did reduce hepatic triglyceride levels, suggesting an indirect mode of action [97]
Yuen, C
Common research applications include in-vitro fibroblast and keratinocyte studies, animal wound-healing models, hair-follicle and dermal-papilla research, post-procedure skin-recovery models, antioxidant-pathway investigations, and gene-expression profiling